Sacubitril-valsartan in the real world: From theory to clinical practice

Sacubitril-valsartan in the real world: From theory to clinical practice

Bibliographic Details
Main Author:	Ricardo Fontes-Carvalho
Format:	Article
Language:	English
Published:	Elsevier 2018-06-01
Series:	Revista Portuguesa de Cardiologia (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2174204918301557

Similar Items

Uso do Sacubitril/Valsartan no «mundo real»: da teoria à prática clínica
by: Ricardo Fontes‐Carvalho
Published: (2018-06-01)

Sacubitril/valsartan: A practical guide
by: Cândida Fonseca, et al.
Published: (2019-05-01)

Sacubitril/valsartan: A practical guide
by: Cândida Fonseca, et al.
Published: (2019-05-01)

Sacubitril/valsartan: A practical guide revisited
by: Cândida Fonseca, et al.
Published: (2019-07-01)

Sacubitril/valsartan: A practical guide revisited
by: Cândida Fonseca, et al.
Published: (2019-07-01)

Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting
by: Charlotte Nordberg Backelin, et al.
Published: (2020-06-01)

Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
by: Maria Vincenza Polito, et al.
Published: (2020-04-01)

Sacubitril/Valsartan in everyday clinical practice: the experience of a heart failure clinic
by: Joana Maria Teixeira Cabral
Published: (2021)

The Diuretic Effect of Sacubitril/Valsartan Might Be Clinically Relevant
by: Luís Beck-da-Silva, et al.

Real-world application of sacubitril/valsartan in patients suffering from heart failure with reduced ejection fraction
by: LUO Xiaoyu, et al.
Published: (2020-11-01)

Antiarrhythmic Effect of Sacubitril-Valsartan: Cause or Consequence of Clinical Improvement?
by: António Valentim Gonçalves, et al.
Published: (2019-06-01)

Sacubitril/valsartan improves cardiac function in Chinese patients with heart failure: a real‐world study
by: Wenwen Chen, et al.
Published: (2021-10-01)

Sacubitril/valsartan vs. angiotensin receptor inhibition in heart failure: a real‐world study in Taiwan
by: Po‐Cheng Chang, et al.
Published: (2020-10-01)

Implementation of sacubitril/valsartan in Sweden: clinical characteristics, titration patterns, and determinants
by: Michael Fu, et al.
Published: (2020-12-01)

Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
by: Cuthbert JJ, et al.
Published: (2020-08-01)

Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma
by: Ulrik Ø Andersen, et al.
Published: (2020-05-01)

Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
by: Sarah L Anderson, et al.
Published: (2018-08-01)

A narrative review on sacubitril/valsartan and ventricular arrhythmias
by: Gao, M., et al.
Published: (2022)

Renin profiling predicts neurohormonal response to sacubitril/valsartan
by: Giuseppe Vergaro, et al.
Published: (2021-02-01)

Effectiveness of sacubitril–valsartan in cancer patients with heart failure
by: Ana Martín‐Garcia, et al.
Published: (2020-04-01)

Real-world treatment switching to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: A cohort study
by: Sashiananthan Ganesananthan, et al.
Published: (2020-12-01)

The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings
by: Alberto Mazza, et al.
Published: (2020-10-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
by: Duygun Altıntaş Aykan, et al.
Published: (2020-10-01)

Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
by: David Carballo, et al.
Published: (2020-06-01)

Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control
by: Jelena P. Seferovic, et al.
Published: (2020-12-01)

Switching to sacubitril/valsartan or adding aldosterone antagonist: which first?
by: Carlos Escobar, et al.
Published: (2019-12-01)

Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view
by: Borja Quiroga, et al.
Published: (2019-11-01)

Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor
by: Ramesh R. Dargad, et al.
Published: (2018-07-01)

Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure
by: Pedro Marques da Silva, et al.
Published: (2017-09-01)

A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan
by: Prashanth Rawla, et al.
Published: (2019-05-01)

Sacubitril/valsartan in heart failure and end‐stage renal insufficiency
by: Alex Heyse, et al.
Published: (2019-12-01)

12. Sacubitril/valsartan in the treatment of systemic right ventricular failure
by: Marieke Nederend, et al.
Published: (2021-02-01)

Renal protective effect of sacubitril/valsartan in patients with heart failure
by: Hui-Ling Hsieh, et al.
Published: (2021-02-01)

Canadian Real-World Experience of Using Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction: Insight From the PARASAIL Study
by: Haissam Haddad, MD, FRCPC, et al.
Published: (2020-09-01)

Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study
by: Swathi Pathadka, et al.
Published: (2021-01-01)

Sacubitril/valsartan in systolic heart failure: A short-term clinical follow-up
by: Vipin Thomas, et al.
Published: (2017-11-01)

Use of sacubitril/valsartan in non‐compaction cardiomyopathy: a case report
by: Marcely Gimenes Bonatto, et al.
Published: (2020-06-01)

Sacubitril/Valsartan for Heart Failure: Exciting Times but Are Doctors Informed and Ready?
by: Prithwish Banerjee
Published: (2017-01-01)

Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
by: Yandrapalli S, et al.
Published: (2017-10-01)

EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
by: Zh. D. Kobalava, et al.
Published: (2017-07-01)